Failure of Costimulatory Blockade-induced Regulatory T Cells to Sustain Long-Term Survival of High Ischemic Allografts.
Sign Up to like & getrecommendations! Published in 2023 at "Transplantation"
DOI: 10.1097/tp.0000000000004570
Abstract: BACKGROUND Costimulatory blockade-induced allograft tolerance has been achieved in rodent models, but these strategies do not translate well to nonhuman primate and clinical transplants. One confounder that may underlie this discrepancy is the greater ischemic… read more here.
Keywords: ischemic allografts; high ischemic; costimulatory blockade; survival ... See more keywords
Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Interventional Cardiology"
DOI: 10.1155/2022/3895205
Abstract: Background There is a paucity of real-world data regarding the clinical impact of dual antiplatelet therapy (DAPT) interruption (temporary or permanent) among patients at high ischemic risk. The aim of this study was to assess… read more here.
Keywords: risk; among patients; ischemic risk; stent driven ... See more keywords
Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI Patients.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of atherosclerosis and thrombosis"
DOI: 10.5551/jat.60129
Abstract: AIMS The ESC/EACTS myocardial revascularization guidelines recently standardized the definition of patients at high ischemic risk (HIR). However, the ability of ESC/EACTS-HIR criteria to stratify ischemic and bleeding risk in a contemporary real-world East Asian… read more here.
Keywords: high ischemic; risk; esc eacts; bleeding ... See more keywords